Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | BlackRock Inc. BLK | 5,620,376 7.600% | 567,531 (+11.23%) | Filing History |
| 2021-11-26 3:23 pm Sale | 2021-10-31 | 13G | Intellia Therapeutics, Inc. NTLA | ARK Investment Management LLC | 7,642,452 10.400% | -3,549,218 (-31.71%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | ARK Investment Management LLC | 11,191,670 17.400% | 2,450,238 (+28.03%) | Filing History |
| 2021-02-11 4:24 pm Sale | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | Amova Asset Management Americas, Inc. | 5,104,362 7.940% | -318,856 (-5.88%) | Filing History |
| 2021-02-10 11:03 am Purchase | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | The Vanguard Group | 5,131,197 7.980% | 1,606,998 (+45.60%) | Filing History |
| 2021-02-05 06:10 am Sale | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | Sumitomo Mitsui Trust Group Inc. | 5,104,362 7.940% | -318,856 (-5.88%) | Filing History |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | BlackRock Inc. BLK | 5,052,845 8.600% | 1,407,615 (+38.62%) | Filing History |